Century Therapeutics (IPSC) Current Leases (2022 - 2025)

Century Therapeutics (IPSC) has 4 years of Current Leases data on file, last reported at $4.9 million in Q2 2025.

• On a quarterly basis, Current Leases rose 33.61% year-over-year to $4.9 million in Q2 2025; TTM through Jun 2025 was $4.9 million, a 33.61% increase from a year earlier, with the FY2024 full-year figure at $4.9 million, up 221.88% from the prior year.
• Current Leases for Q2 2025 stood at $4.9 million, roughly flat from $4.9 million in the prior quarter.
• Over the last five years, Current Leases for IPSC reached as high as $4.9 million in Q2 2025 and fell as low as $475000.0 in Q4 2022.
• Historically, Current Leases has averaged $3.1 million across 4 years, with a median of $3.7 million in 2024.
• Across the five-year window, Current Leases surged 221.88% in 2024 and jumped 33.61% in 2025, its largest moves.
• Year by year, Current Leases stood at $475000.0 in 2022, then jumped by 218.53% to $1.5 million in 2023, then jumped by 221.88% to $4.9 million in 2024, then increased by 0.49% to $4.9 million in 2025.
• Per Business Quant data, the three most recent Current Leases figures were $4.9 million in Q2 2025, $4.9 million in Q1 2025, and $4.9 million in Q4 2024.